FRE.DE 36.38 (+2.19%)
DE0005785604Healthcare Providers & ServicesMedical Care Facilities

Fresenius SE (FRE.DE) Stock Highlights

36.38 | +2.19%
2025-01-21 00:35:51
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care, which accounts for about half of its consolidated revenue. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Statistics

Range Today
36.2 36.59
Volume Today 576.34K
Range 1 Year
24.32 36.24
Volume 1 Year 241.83M
Range 3 Year
19.69 38.1
Volume 3 Year 948.38M
Range 10 Year
19.69 80.07
Volume 10 Year 3.62B

Highlights

Market Capitalization 21.06B (large)
Floating Shares 410.98M
Current Price 36.38
Price To Earnings 43.6
Price To Revenue 1.44
Price To Book 1.09
Earnings Per Share 0.82
Payout Ratio 0%

Performance

Latest +2.19%
1 Month +9.28%
3 Months +8.79%
6 Months +20.78%
1 Year +37.86%
3 Years -2.15%
5 Years -24.8%
10 Years -24.83%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.